Steven Cohen’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Steven Cohen's NVCR Position: Q3 2026 in Review
Steven Cohen reduced its NovoCure (NVCR) stake by 24% in Q3 2026, selling an estimated $3.26M and leaving 607,780 shares worth $9.7M. The position accounts for 0.01% of the portfolio, ranked #1373.
Steven Cohen first reported a position in NVCR in Q1 2019 and has held it in 12 quarters since. The position peaked at $14.8M in Q1 2026. 242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Steven Cohen held 607,780 shares of NovoCure worth $9.7M as of Q3 2026.
- Steven Cohen sold 195,340 NovoCure shares in Q3 2026, an estimated $3.26M.
- NovoCure made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1373 holding.
- Steven Cohen first reported a position in NovoCure in Q1 2019 and has held it in 12 quarters since.
- Steven Cohen's NovoCure position peaked at $14.8M in Q1 2026.
- 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.